JDRF's venture arm gets a new partner

A new managing partner at the JDRF T1D fund — the only venture firm focused on type 1 diabetes — wants to catalyze faster development of treatments for the autoimmune pancreatic disease. 

Steven St. Peter, who ran his own VC firm — Vie Ventures — and also was a managing director at MPM Capital, says one focus will be to help existing biopharma companies pivot part of their pipeline toward type 1 diabetes.  

The four-year-old fund manages about $90 million; about half of that has been committed to the company’s 16 portfolio companies. 

Read more.